XT
LYEL icon

XTX Topco’s Lyell Immunopharma LYEL Stock Holding History

XTX Topco’s Portfolio LYEL Stock Details LYEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-3,509
Closed -$102K – 2380
2024
Q2 		$102K Sell
3,509
-2,027
-37% -$96.5K 0.01% 1416
2024
Q1 		$247K Sell
5,536
-2,234
-29% -$95.7K 0.03% 1007
2023
Q4 		$301K Buy
7,770
+2,034
+35% +$73.2K 0.07% 611
2023
Q3 		$169K Buy
+5,736
New +$272K 0.03% 1072
2023
Q2 		– Sell
-14,331
Closed -$676K – 1645
2023
Q1 		$676K Buy
14,331
+13,550
+1,735% +$725K 0.14% 154
2022
Q4 		$54.2K Buy
+781
New +$77.6K 0.01% 1039

Other funds holding LYEL

MM
MWG Management Road Town, Tortola, British Virgin Islands $81.3M AUM 2.28% 1-Year Est. Return
OPL
Orland Properties Ltd Road Town, Tortola, British Virgin Islands $202M AUM 2.79% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $290M AUM 143.88% 1-Year Est. Return
WA
WuXi AppTec Shanghai, China $19M AUM 20.22% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

XTX Topco's LYEL Position: Q3 2024 in Review

XTX Topco sold out of Lyell Immunopharma (LYEL) in Q3 2024, closing a stake of 3,509 shares — an estimated $102K sold.

XTX Topco first reported a position in LYEL in Q4 2022 and held it in 6 quarters. The position peaked at $676K in Q1 2023. 117 funds tracked by Wall St. Rank hold LYEL as of Q3 2024.

  • XTX Topco reported no remaining Lyell Immunopharma position as of Q3 2024 after selling out during the quarter.
  • XTX Topco sold 3,509 Lyell Immunopharma shares in Q3 2024, an estimated $102K.
  • XTX Topco first reported a position in Lyell Immunopharma in Q4 2022 and held it in 6 quarters.
  • XTX Topco's Lyell Immunopharma position peaked at $676K in Q1 2023.
  • 117 funds tracked by Wall St. Rank held Lyell Immunopharma as of Q3 2024.

Based on XTX Topco's 13F filing for Q3 2024, filed 14 Nov 2024.